• «Great obstetrical syndromes» – current opportunities of prevention

«Great obstetrical syndromes» – current opportunities of prevention

HEALTH OF WOMAN. 2018.5(132):67–72; doi 10.15574/HW.2018.132.67

Romanenko T. G. , Sulimenko O. M.
Shupyk National Medical Academy of Postgraduate Education, Kiev

The objective: was to reduce the incidence and severity of the development of «Great Obstetrical Syndromes»: miscarriage of pregnancy, placental insufficiency, fetal growth retardation and / or fetal distress, preeclampsia, premature detachment of a normally located placenta, premature delivery, by developing an algorithm for prophylaxis during pregnancy in women at high risk for their development.

Materials and methods. Clinical and statistical analysis of pregnancy in 88 pregnant women with high risk of decompensation of placental insufficiency was conducted. Depending on the method of preventing complications, 2 groups were formed. The I group included 58 pregnant women who were offered the following algorithm: micronized progesterone 200 mg PV from 6 to 20 weeks of gestation; from 21 to 26 weeks of gestation and from 31 to 36 weeks; phleboprotector with ultra-micronized fractions of bioflavonoids (Flego) 15 ml per os; with subsequent appointment from 21 to 26 weeks of gestation; and from 31 to 36 weeks. Group II included 30 pregnant women who had abandoned any proposed prophylactic measures. The control group consisted of 30 healthy pregnant women. Clinical and statistical analysis of pregnancy in the study groups was conducted.

During statistical processing, personal computer and software Microsoft Excel XP and Statistica 6.0 Windows, methods of descriptive statistics, correlation analysis were used. The reliability of the difference between the indicators is estimated by the Student-Fisher criterion.

Results. The method of prophylaxis of «Great Obstetrical Syndromes» by sequential administration from the early stages of pregnancy of micronized progesterone with the following appointment – from the second trimester of pregnancy – showed a high efficacy of the phleboprotector, which is manifested in a significantly lower number of cases of preeclampsia in the main group of 3.5% (2) versus 50% (15) in the control group, placental insufficiency was 13.8% (8) versus 100% (30); fetal growth retardation was 5.2% (3) versus 56.7% (17); fetal distress was 3.5% (2) versus 43 , 3% (13), preterm labor 1.7% (1) versus 13.3% (4) and in the absence of premature detachment normal but located on the placenta, severe forms of preeclampsia and placental insufficiency.

Conclusions. Pregnant of «Great Obstetrical Syndromes» risk groups need timely prophylactic measures to reduce the likelihood of a pathological pregnancy and improve perinatal outcomes. The proposed prophylaxis scheme significantly lowered the incidence of large obstetric syndromes and improved neonatal outcomes.

Key words: great obstetrical syndromes, pathological pregnancy, placental dysfunction, phleboprotector.

REFERENCES

1. Nosenko EN, Zhuk SI, Rutinskaya AV. 2017. Problemnyie voprosyi bolshih akusherskih sindromov. Zhurnal «Zhinochiy likar» 2(70):28–35.

2. Strizhakov AN, Lipatov IS, Tezikov YuV. 2014. Platsentarnaya nedostatochnost: Patogenez. Prognozirovanie. Diagnostika. Profilaktika. Akusherskaya taktika. Samara, OFORT.

3. Kravchenko YuL, Lipatov IS, Danilova NN, Toporova IB, Tezikov YuV, Kryilova OL. 2006. Aspektyi profilaktiki sotsialnyih i ekologicheskih faktorov riska perinatalnoy smertnosti v usloviyah gorodskoy klinicheskoy bolnitsyi krupnogo promyishlennogo goroda. Chelovek i Vselennaya 56(3):119–32.

4. Tezikov YuV, Lipatov IS, Frolova NA, Kutuzova OA, Prihodko AV. 2017. Metodologiya profilaktiki bolshih akusherskih sindromov. Zhurnal «Medichni aspekty zdorov’ya zhinky» 7–8(112–113):33–43.

5. Lipatov IS, Tezikov YuV, Byikov AV, Nasihullina RN, Ergunova GA, Potapova IA i dr. 2006. Apoptoz i ego rol v formirovanii fetoplatsentarnoy nedostatochnosti. Vestnik Samarskogo gosudarstvennogo universiteta 44(4-4):220-6.

6. Potapova IA, Purygin PP, Belousova ZP, Selezneva ES, Lipatov IS, Tezikov YV. 2001. Syntesis and biological activity of aliphatic and aromatic sulfonical acid azolides. Pharmaceutical Chemistry Yournal. 35(11):588–90. https://doi.org/10.1023/A:1015133508283

7. Tezikov YuV, Lipatov IS. 2011. Rezultatyi primeneniya karbogenoterapii dlya profilaktiki platsentarnoy nedostatochnosti. Rossiyskiy vestnik akushera-ginekologa 11(5):71–7.

8. Strizhakov AN, Lipatov IS, Tezikov YuV. 2012. Kompleksnaya otsenka stepeni tyazhesti hronicheskoy platsentarnoy nedostatochnosti. Akusherstvo i ginekologiya 3:20–5.

9. Saveleva GM, Panina OB, Kurtser MA, Gnetetskaya VA, Bugerenko EYu, Konovalova OV. 2010. Prenatalnyiy period: fiziologiya i patologiya. Rossiyskiy vestnik akushera-ginekologa 10(2):61–5.

10. Strizhakov AN, Tezikov YuV, Lipatov IS, Sharyipova MA, Anpilogova IV, Azizov KU i dr. 2014. Standartizatsiya diagnostiki i klinicheskaya klassifikatsiya hronicheskoy platsentarnoy nedostatochnosti. Voprosyi ginekologii, akusherstva i perinatologii 13(3):5–12.

11. Brosens I, Pijnenborg R, Vercruysse L, Romero R. 2011. The «Great Obstetrical Syndromes» are associated with disorders of deep placentation. Am J Obstet Gynec. 204(3):193–201. https://doi.org/10.1016/j.ajog.2010.08.009; PMid:21094932 PMCid:PMC3369813

12. Murashko AV. 2000. Etiologiya i patogenez hronicheskoy venoznoy nedostatochnosti pri beremennosti. Problemyi beremennosti 2:16–21.